Johnson & Johnson (JNJ)

NYSE HEALTHCARE
$225.33 -2.37% RSI 42 Neutral Add Alert

Moving Averages

SMA 50
$231.27
Price near
SMA 200
$207.72
Price above
EMA 20
$228.33
Price near

Company Profile

Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government.

Sector
HEALTHCARE
Industry
DRUG MANUFACTURERS - GENERAL
Market Cap
$532.77B
P/E Ratio
25.65
EPS
$8.63
Beta
0.263
Dividend Yield
2.34%
52-Week High
$251.71
52-Week Low
$142.16

Insider Transactions

ExecutiveTitleActionSharesDate
REED, JOHN CEVP, Innovative Medicine, R&DBuy25,2552026-05-01
REED, JOHN CEVP, Innovative Medicine, R&DSell11,0022026-05-01
REED, JOHN CEVP, Innovative Medicine, R&DSell25,2552026-05-01
Continue with Google

Latest News

Earnings Call Transcript

Johnson & Johnson Q1 2026 — Hello, everyone. This is Darren Snellgrove, Vice President of Investor Relations for Johnson & Johnson. Welcome to our company's review of business results for the first quarter of 2026, and our financial outlook for the full year. First, a few logistics. As a reminder, today's presentation and associated schedules are available on the Investor Relations section of the Johnson & Johnson website at investor.jnj.com. Please note that this presentation contains forward-looking statements regarding, among other things, the company's future operating and financial performance, market position and b…

Continue with Google

Options Chain

TypeStrikeExpiryVolumeOpen Interest
Put$210.002026-06-181,5335,309
Call$230.002026-07-171,3946,157
Call$240.002026-07-177704,240
Continue with Google

Similar stocks in DRUG MANUFACTURERS - GENERAL

LLY
Lilly(Eli) & Company
RSI 64.0
PFE
Pfizer Inc
RSI 43.0
BMY
Bristol-Myers Squibb Company
RSI 36.0
MRK
Merck & Co Inc
RSI 49.0
NVO
Novo Nordisk
RSI 51.0
ABBV
Abbvie Inc
RSI 53.0
GILD
Gilead Sciences Inc
RSI 44.0
AMGN
AMGEN Inc
RSI 43.0
GSK
GSK Plc
RSI 35.0
OGN
Organon & Company
RSI 75.0

Data last updated: May 31, 2026 at 11:14 PM EDT

Track JNJ for free

Get e-mail RSI alerts when Johnson & Johnson enters oversold or overbought territory. Free forever.

Add Alert